Rare diseases
Investigational molecules
Locations
Fruebjergvej 3, 2100 Copenhagen, Denmark
Scandion Oncology A/S focuses on metastatic colorectal cancer, with research centred on treatment-resistant disease and the need for more effective systemic options in advanced gastrointestinal oncology.
The sponsor’s clinical activity is directed toward patients whose disease has progressed despite prior chemotherapy, reflecting interest in difficult-to-treat oncology settings.
Scandion Oncology A/S runs clinical trials in conditions such as Colorectal cancer metastatic, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
